These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7168488)

  • 21. Resolution of focal CT hypodense lesions in patients with subarachnoid hemorrhage.
    Baker CJ; Ortiz O; Solomon RA
    Surg Neurol; 1993 Feb; 39(2):158-62. PubMed ID: 8351629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood transfusion therapy is feasible in a clinical trial setting in children with sickle cell disease and silent cerebral infarcts.
    King AA; Noetzel M; White DA; McKinstry RC; Debaun MR
    Pediatr Blood Cancer; 2008 Mar; 50(3):599-602. PubMed ID: 17985350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Superior sagittal sinus thrombosis with infarction in sickle cell trait.
    Feldenzer JA; Bueche MJ; Venes JL; Gebarski SS
    Stroke; 1987; 18(3):656-60. PubMed ID: 3296334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cerebral infarction and subarachnoid hemorrhage caused by dolichoectasia; report of a case].
    Kuroda S; Nakagawa Y; Kitaoka K; Hida K; Kitagawa M; Miyagishima T; Tateyama M
    No Shinkei Geka; 1988 Sep; 16(10):1187-92. PubMed ID: 3060750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overt and incomplete (silent) cerebral infarction in sickle cell anemia: diagnosis and management.
    Wong WY; Powars DR
    Neuroimaging Clin N Am; 2007 May; 17(2):269-80. PubMed ID: 17645976
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discontinuation of long-term transfusion therapy in patients with sickle cell disease and stroke.
    Rana S; Houston PE; Surana N; Shalaby-Rana EI; Castro OL
    J Pediatr; 1997 Nov; 131(5):757-60. PubMed ID: 9403661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stroke prevention trial in sickle cell anemia.
    Adams RJ; McKie VC; Brambilla D; Carl E; Gallagher D; Nichols FT; Roach S; Abboud M; Berman B; Driscoll C; Files B; Hsu L; Hurlet A; Miller S; Olivieri N; Pegelow C; Scher C; Vichinsky E; Wang W; Woods G; Kutlar A; Wright E; Hagner S; Tighe F; Waclawiw MA
    Control Clin Trials; 1998 Feb; 19(1):110-29. PubMed ID: 9492971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence of overt and covert neurological damage in children with sickle cell disease.
    Hindmarsh PC; Brozovic M; Brook CG; Davies SC
    Postgrad Med J; 1987 Sep; 63(743):751-3. PubMed ID: 3444798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of transcranial ultrasonography to predict stroke in sickle cell disease.
    Adams R; McKie V; Nichols F; Carl E; Zhang DL; McKie K; Figueroa R; Litaker M; Thompson W; Hess D
    N Engl J Med; 1992 Feb; 326(9):605-10. PubMed ID: 1734251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anemia After Aneurysmal Subarachnoid Hemorrhage Is Associated With Poor Outcome and Death.
    Ayling OGS; Ibrahim GM; Alotaibi NM; Gooderham PA; Macdonald RL
    Stroke; 2018 Aug; 49(8):1859-1865. PubMed ID: 29946013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nonaneurysmal Subarachnoid Hemorrhage in Sickle Cell Disease: Description of a Case and a Review of the Literature.
    Zuccoli G; Nardone R; Rajan D; Khan AS; Cummings DD
    Neurologist; 2018 Jul; 23(4):122-127. PubMed ID: 29953035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cerebral infarction in sickle cell anemia: mechanism based on CT and MRI.
    Adams RJ; Nichols FT; McKie V; McKie K; Milner P; Gammal TE
    Neurology; 1988 Jul; 38(7):1012-7. PubMed ID: 3386816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tonsillectomy, adenoidectomy, and myringotomy in sickle cell disease: perioperative morbidity. Preoperative Transfusion in Sickle Cell Disease Study Group.
    Waldron P; Pegelow C; Neumayr L; Haberkern C; Earles A; Wesman R; Vichinsky E
    J Pediatr Hematol Oncol; 1999; 21(2):129-35. PubMed ID: 10206459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intracranial aneurysms in sickle cell patients: report of 2 cases and review of the literature.
    Brandão RA; de Carvalho GT; Reis BL; Bahia E; de Souza AA
    Surg Neurol; 2009 Sep; 72(3):296-9; discussion 299. PubMed ID: 18614211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sulcus subarachnoid hemorrhage is a common stroke subtype in patients with implanted left ventricular assist devices.
    Sakaguchi M; Kitagawa K; Okazaki S; Yoshioka D; Sakata Y; Mochizuki H; Sawa Y; Yoshimine T
    Eur J Neurol; 2015 Jul; 22(7):1088-93. PubMed ID: 25855522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accuracy of neurologic examination and history in detecting evidence of MRI-diagnosed cerebral infarctions in children with sickle cell hemoglobinopathy.
    Glauser TA; Siegel MJ; Lee BC; DeBaun MR
    J Child Neurol; 1995 Mar; 10(2):88-92. PubMed ID: 7782614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Encephaloduroarteriosynangiosis and encephalomyoarteriosynangiosis for treatment of moyamoya syndrome in pediatric patients with sickle cell disease.
    Griessenauer CJ; Lebensburger JD; Chua MH; Fisher WS; Hilliard L; Bemrich-Stolz CJ; Howard TH; Johnston JM
    J Neurosurg Pediatr; 2015 Jul; 16(1):64-73. PubMed ID: 25837886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advances in neuroimaging to improve care in sickle cell disease.
    Jordan LC; DeBaun MR; Donahue MJ
    Lancet Neurol; 2021 May; 20(5):398-408. PubMed ID: 33894194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathophysiology and treatment of stroke in sickle-cell disease: present and future.
    Switzer JA; Hess DC; Nichols FT; Adams RJ
    Lancet Neurol; 2006 Jun; 5(6):501-12. PubMed ID: 16713922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebral CT and MRI findings in cervicocephalic artery dissection.
    Pelkonen O; Tikkakoski T; Pyhtinen J; Sotaniemi K
    Acta Radiol; 2004 May; 45(3):259-65. PubMed ID: 15239419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.